These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 12374430)

  • 41. [Cell therapy for Parkinson's disease].
    Morizane A; Takahashi J
    Nihon Yakurigaku Zasshi; 2016 May; 147(5):264-8. PubMed ID: 27181719
    [No Abstract]   [Full Text] [Related]  

  • 42. Walking pattern analysis after unilateral 6-OHDA lesion and transplantation of foetal dopaminergic progenitor cells in rats.
    Klein A; Wessolleck J; Papazoglou A; Metz GA; Nikkhah G
    Behav Brain Res; 2009 May; 199(2):317-25. PubMed ID: 19124044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transplanted allogeneic fetal dopamine neurons survive and improve motor function in idiopathic Parkinson's disease.
    Widner H; Brundin P; Rehncrona S; Gustavii B; Frackowiak R; Leenders KL; Sawle G; Rothwell JC; Marsden CD; Björklund A
    Transplant Proc; 1991 Feb; 23(1 Pt 1):793-5. PubMed ID: 1990693
    [No Abstract]   [Full Text] [Related]  

  • 44. Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective.
    Hagell P; Cenci MA
    Brain Res Bull; 2005 Dec; 68(1-2):4-15. PubMed ID: 16324999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease.
    Björklund LM; Isacson O
    Prog Brain Res; 2002; 138():411-20. PubMed ID: 12432781
    [No Abstract]   [Full Text] [Related]  

  • 46. Dyskinesias following neural transplantation in Parkinson's disease.
    Hagell P; Piccini P; Björklund A; Brundin P; Rehncrona S; Widner H; Crabb L; Pavese N; Oertel WH; Quinn N; Brooks DJ; Lindvall O
    Nat Neurosci; 2002 Jul; 5(7):627-8. PubMed ID: 12042822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two-step grafting significantly enhances the survival of foetal dopaminergic transplants and induces graft-derived vascularisation in a 6-OHDA model of Parkinson's disease.
    Büchele F; Döbrössy M; Hackl C; Jiang W; Papazoglou A; Nikkhah G
    Neurobiol Dis; 2014 Aug; 68():112-25. PubMed ID: 24780496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients.
    Levivier M; Dethy S; Rodesch F; Peschanski M; Vandesteene A; David P; Wikler D; Goldman S; Claes T; Biver F; Liesnard C; Goldman M; Hildebrand J; Brotchi J
    Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):99-111. PubMed ID: 9711741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neural transplantation, trophic factors and Parkinson's disease.
    Kupsch A; Oertel WH
    Life Sci; 1994; 55(25-26):2083-95. PubMed ID: 7997067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neural transplantation (auto-adrenal, fetal nigral and fetal adrenal) in Parkinson's disease: the Mexican experience.
    Madrazo I; Franco-Bourland R; Ostrosky-Solis F; Aguilera M; Cuevas C; Alvarez F; Magallon E; Zamorano C; Morelos A
    Prog Brain Res; 1990; 82():593-602. PubMed ID: 1981281
    [No Abstract]   [Full Text] [Related]  

  • 51. Ethical aspects of neural tissue transplantation.
    Hildt E
    Croat Med J; 1999 Sep; 40(3):326-33. PubMed ID: 10411958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.
    Sortwell CE; Collier TJ; Camargo MD; Pitzer MR
    Exp Neurol; 2004 May; 187(1):58-64. PubMed ID: 15081588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell transplantation in Parkinson's disease: problems and perspectives.
    Allan LE; Petit GH; Brundin P
    Curr Opin Neurol; 2010 Aug; 23(4):426-32. PubMed ID: 20489615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neural transplantation for Parkinson's disease.
    Date I; Ohmoto T
    Cell Mol Neurobiol; 1999 Feb; 19(1):67-78. PubMed ID: 10079966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells.
    Agrawal AK; Shukla S; Chaturvedi RK; Seth K; Srivastava N; Ahmad A; Seth PK
    Neurobiol Dis; 2004 Aug; 16(3):516-26. PubMed ID: 15262263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do patients with Parkinson's disease benefit from embryonic dopamine cell transplantation?
    Freed CR; Leehey MA; Zawada M; Bjugstad K; Thompson L; Breeze RE
    J Neurol; 2003 Oct; 250 Suppl 3():III44-6. PubMed ID: 14579124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson's disease.
    Tsui A; Isacson O
    J Neurol; 2011 Aug; 258(8):1393-405. PubMed ID: 21544566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.
    Kordower JH; Goetz CG; Chu Y; Halliday GM; Nicholson DA; Musial TF; Marmion DJ; Stoessl AJ; Sossi V; Freeman TB; Olanow CW
    Ann Neurol; 2017 Jan; 81(1):46-57. PubMed ID: 27900791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Update on fetal transplantation: the Swedish experience.
    Lindvall O
    Mov Disord; 1998; 13 Suppl 1():83-7. PubMed ID: 9613723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
    Lane EL; Brundin P; Cenci MA
    Neurobiol Dis; 2009 Jul; 35(1):42-51. PubMed ID: 19361557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.